Payment Trends: Is the New Drug Sample Reporting Requirement a Message on the Wall for Pharma?
HHS could use the data it collects from drug companies to answer this key question.
Starting in 2012, drug companies must fork over annual reports to HHS spelling out the types and volumes of drug samples they've tendered to individual physicians. And that data could open a window into a world that the government may be hankering to analyze. Baltimore attorney Joshua Freemire thinks the reporting requirement, which is mandated by the healthcare reform legislation, could be designed to give "federal authorities the data they need to assess how the free sample system affects prescription patterns." (He emphasizes...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: